Non-medication treatment for adult ADHD: what the evidence supports

First, plainly: Dr. Shershow's listed services are psychiatric evaluation and medication management. Therapy, CBT and coaching are not among them. This page is here because many adults want to know their options, some prefer not to take medication, and medication alone does not solve everything. Anything below would be arranged with another professional.

The field has a mixed evidence base. Some treatments have many trials, others almost none, and some look better when the person rating knows who received treatment. Here is a summary, followed by the details.

The ratings in that table are this page's plain-language summary of the studies below. They are not an official grading.

What NICE says

NICE, the UK's guideline body, recommends offering medication to adults whose symptoms still cause significant impairment after environmental changes have been made and reviewed. It says to consider non-drug treatment for adults who have made an informed choice not to take medication, have difficulty taking it consistently, or have found it ineffective or intolerable. It also says to consider adding non-drug treatment for those who have benefited from medication but remain significantly impaired.

When non-drug treatment is indicated, NICE advises at least a structured supportive psychological intervention focused on ADHD, plus regular follow-up in person or by phone, which may include elements or a full course of CBT. NICE's rationale says the evidence showed a benefit, but one smaller than medication's. NICE also stresses the value of a balanced diet, good nutrition and regular exercise.

Cognitive behavioral therapy

CBT for ADHD aims to change thoughts and behaviors that keep problems going, using specific techniques for planning and managing symptoms. The findings:

• Cochrane review, 2018. Across 14 trials and 700 adults, the authors found low-quality evidence that CBT may benefit adults in the short term, with fairly consistent symptom reductions compared with a waiting list and when added to medication. Long-term data were scarce.
• Safren, JAMA, 2010. In 86 adults already on medication who still had symptoms, 12 sessions of CBT produced more responders than relaxation with educational support (67% versus 33% on an ADHD rating scale), and gains held over 12 months.
• BMJ umbrella review, 2025. Gosling and colleagues found moderate-certainty evidence that CBT reduces clinician-rated adult ADHD symptoms, with medium effect sizes. No intervention had high-certainty long-term evidence.
• Lancet Psychiatry, 2025. Ostinelli and colleagues analyzed 113 trials and 14,887 adults. CBT, mindfulness and psychoeducation beat placebo only on clinician-reported measures. Stimulants and atomoxetine were the only treatments that helped on both self-reported and clinician-reported ratings in the short term. The authors note that non-drug effects were inconsistent across raters, and that medications did not show benefit on some outcomes such as quality of life.

The honest reading: CBT has real support, particularly as an add-on for people with remaining symptoms. It is not proven to be equal to medication for core symptoms. For a guide to finding it, see finding ADHD therapy and CBT in New York.

Skills training

Solanto's 2010 trial tested a 12-week group meta-cognitive therapy that teaches time management, organization and planning in 88 adults. It beat supportive therapy on inattention symptoms by self-report, by collateral report and by independent evaluator. The German COMPAS trial was larger. In 419 adults, a highly structured cognitive behavioral group program did not beat individual clinical management on the primary outcome, while methylphenidate did better than placebo. Over a year, the group format did score better on one global effectiveness rating, and psychological treatments went better when combined with methylphenidate. One reading is that structured attention from a clinician helps, and that specific program content may matter less than expected, though that trial alone cannot settle it.

Mindfulness

In a Dutch multicenter trial of 120 adults, Janssen and colleagues added 8 weekly sessions of mindfulness-based cognitive therapy to usual treatment. Blinded clinicians rated a significant reduction in ADHD symptoms, which lasted to 6 months, and 27% had at least a 30% reduction versus 4% on usual care alone. The BMJ review, however, rates the evidence for mindfulness in adults as low certainty, despite large effects.

Coaching

NIMH says some adults may find it helpful to get support from a life coach or ADHD coach who can teach executive function skills. The research base is thin. A study by Prevatt and colleagues followed 148 college students through an 8-week program and found improvements in study skills, self-esteem and symptom distress, but it had no randomized control group, and the authors called for one. Before paying for it, read ADHD coaching in New York, which covers credentials and licensing.

Exercise

A 2026 meta-analysis by Xu and colleagues found that a single session of exercise had a moderate positive effect on inhibitory control and a small benefit on core symptoms in adults with ADHD. Evidence for longer exercise programs was mixed, and the authors call the findings preliminary. A 2025 meta-analysis also reported better inhibitory control with physical activity, based on 373 participants. NICE stresses the value of regular exercise for adults with ADHD, but the current evidence does not make it a proven replacement for treatment.

Sleep

NIMH reports sleep problems in up to 70% of adults with ADHD. Whether treating insomnia changes ADHD symptoms is unclear, but insomnia is worth treating in its own right. A small 2019 Swedish pilot of 19 patients, with no control group, found improved insomnia severity after group CBT for insomnia adapted for ADHD. A 2026 Danish trial of 88 outpatients with depression, attention deficit disorder or bipolar disorder found better sleep quality, well-being and work ability than with sleep hygiene education, though actigraphy and sleep diaries showed no difference between groups. A 2025 review found short-term benefit from CBT for insomnia in people with autism or ADHD, while improvements in condition-specific characteristics were inconsistent and mostly not maintained. See ADHD and insomnia.

Neurofeedback

This has the clearest negative result. In a 2017 triple-blind trial of 118 adults, neurofeedback was no better than sham neurofeedback or group therapy, and all groups improved. A 2025 meta-analysis of 38 trials (2,472 participants aged 5 to 40) found no significant improvement on probably blinded ratings, a small improvement in trials using established standard protocols, and concluded that neurofeedback did not appear to meaningfully benefit people with ADHD at the group level.

Digital tools

The FDA's database lists EndeavorOTC as cleared on June 14, 2024. It is a digital therapeutic indicated to improve attention function as measured by computer-based testing in patients 18 and older with primarily inattentive or combined type ADHD. The adult trial enrolled 221 people and showed improvement on an attention test, and adverse device effects across that trial and a companion adolescent trial were mild or moderate. Its single-arm design limits what it can show. Clearance is not a finding that a tool is as effective as other treatments. This page did not assess ordinary reminder apps and planners, which may still be practical supports.

How to decide

A reasonable question is what problem you are trying to solve. Core symptoms, daily organization, sleep and co-occurring anxiety may each call for something different. A psychiatric evaluation can clarify the diagnosis and whether medication makes sense, and the adult ADHD treatment page outlines what the practice does. Therapy or coaching would be separate, with a professional you choose. Dr. Shershow evaluates and treats adults with ADHD located in New York or New Jersey. You can read more about the adult ADHD evaluation.